Parimifasor (LYC-30937) is an orally active agent for inflammatory bowel disease. Parimifasor targets F1F0-ATPase. Parimifasor acts on respiratory complex V, slows ATP production and induces Apoptosis. Parimifasor can be used in the research of inflammatory bowel disease[1].
Molecular Weight:
460.21
Purity:
98.53
CAS Number:
[1796641-10-5]
Formula:
C18H11Cl2F4N5O
Target:
Apoptosis,ATP Synthase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted